Teladoc Health, Inc. (TDOC) research
Teladoc Health, Inc.- Sector
- Health Care
- Last price
- $6.14
- As of
Teladoc Health, Inc. (TDOC): 7 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-31.
As of . Source: SEC EDGAR filings for TDOC. Method and limitations.
Share the TDOC intelligence card
See TDOC live in the terminal
Track TDOC's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live TDOC terminal, freeActive signals for TDOC
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 100% of TDOC (2026Q2)
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +18010% to TDOC (2026Q2)
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 84% of TDOC (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 90% of TDOC (2026Q2)
- highINSTITUTIONAL_EXIT
D. E. Shaw & Co., Inc. cut 56% of TDOC (2026Q2)
FREE, NO ACCOUNT
Every signal on TDOC, as it fires
You are seeing 5 of 31 signals recorded on TDOC since 2026-05-30.
The five above all landed on 2026-09-06. The other 26 were recorded on 4 other days. 27 of the 31 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in TDOC (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc.CUSIP 87918AAF2 · 2026Q2 | $146.1M | 0.07% | , |
| Point72 Asset Management, L.P.CUSIP 87918A105 · 2026Q2 | $69.9M | 0.08% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 87918A105 · 2026Q2 | $68.5M | 0.09% | , |
| CITADEL ADVISORS LLCCUSIP 87918A105 · 2026Q2 | $6.5M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 87918A105 · 2026Q2 | $5.4M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 87918A105 · 2026Q2 | $1.2M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 87918A105 · 2026Q2 | $1.2M | 0.00% | , |
| Bridgewater Associates, LPCUSIP 87918A105 · 2026Q2 | $100K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, TDOC
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
TDOC against its peers
TDOC's operating margin of -10.4% ranks in the 33rd percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-10-03 and 2026-05-31.
| Metric | TDOC | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 2.5B USD | 764M USD | 83 | 25 |
| Gross margin | n/a | 59.2% | n/a | 16 |
| Operating margin | -10.4% | 1.4% | 33 | 25 |
| Net margin | -7.9% | -0.4% | 33 | 25 |
| Return on equity | -14.5% | -0.9% | 37 | 25 |
| P / E | n/a | 47.2x | n/a | 9 |
Peers (25): GDRX, IRMD, PRCT, CSTL, TNDM, USPH, STAA, CERT, OMDA, AMN, CNMD, PNTG, BVS, TALK, OMCL, HSTM, ATEC, VREX, AHCO, LMAT, EHAB, NVCR, XRAY, SEM, ANGO. Fiscal periods ending between 2025-10-03 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (TDOC: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more TDOC signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to TDOCand get the insider, 13F, options, and confluence read in one view.